TGF-[beta]2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing

Background Mesenchymal stem cells (MSCs) secrete paracrine factors and extracellular matrix proteins that contribute to their ability to support tissue healing and regeneration. Both the transcriptome and the secretome of MSCs can be altered by treating the cells with cytokines, but neither have bee...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cell research & therapy 2022-09, Vol.13 (1)
Hauptverfasser: Koch, Drew W, Schnabel, Lauren V, Ellis, Ilene M, Bates, Rowan E, Berglund, Alix K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title Stem cell research & therapy
container_volume 13
creator Koch, Drew W
Schnabel, Lauren V
Ellis, Ilene M
Bates, Rowan E
Berglund, Alix K
description Background Mesenchymal stem cells (MSCs) secrete paracrine factors and extracellular matrix proteins that contribute to their ability to support tissue healing and regeneration. Both the transcriptome and the secretome of MSCs can be altered by treating the cells with cytokines, but neither have been thoroughly investigated following treatment with the specific cytokine transforming growth factor (TGF)-[beta]2. Methods RNA-sequencing and western blotting were used to compare gene and protein expression between untreated and TGF-[beta]2-treated equine bone marrow-derived MSCs (BM-MSCs). A co-culture system was utilized to compare equine tenocyte migration during co-culture with untreated and TGF-[beta]2-treated BM-MSCs. Results TGF-[beta]2 treatment significantly upregulated gene expression of collagens, extracellular matrix molecules, and growth factors. Protein expression of collagen type I and tenascin-C was also confirmed to be upregulated in TGF-[beta]2-treated BM-MSCs compared to untreated BM-MSCs. Both untreated and TGF-[beta]2-treated BM-MSCs increased tenocyte migration in vitro. Conclusions Treating equine BM-MSCs with TGF-[beta]2 significantly increases production of paracrine factors and extracellular matrix molecules important for tendon healing and promotes the migration of tenocytes in vitro. Keywords: Mesenchymal stem cell, Tenocyte, TGF-[beta], Equine, Tendon, RNA-sequencing, Paracrine factors, Extracellular matrix
doi_str_mv 10.1186/s13287-022-03172-9
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A718024194</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A718024194</galeid><sourcerecordid>A718024194</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1324-99473d9e5a29703ece9229afb1d9e160315b8b8a523e0ab1bf28e59eb8c4d96d3</originalsourceid><addsrcrecordid>eNptkMlKBDEQhhtRUNQX8BQQBA_RJL3mKKKjIAguJ5GhOl09He1OtCvj6FP4ysblMAMmkArF99fyJ8meFEdSVsUxyVRVJRdKcZHKUnG9lmzJMi95kUu1vvTfTHaJnkQ8aSpEkW0ln3eTc_5QY4BHxdB14AwSw_eXEYmsd8y3DF_n1iGrfXwGGEe_4A2O9g0bNiChM93HAD2jgAMz2PfsBUYw47emBRP8SGxhQ8eenV84BkTeWAixOLHgWUDXxD4dQm_dbCfZaKEn3P2L28n9-dnd6QW_up5cnp5c8VlcNuNaZ2XaaMxB6VKkaFArpaGtZUzKItqQ11VdQa5SFFDLulUV5hrrymSNLpp0O9n_rTuDHqfWtT7EmQdLZnpSykqoTOosUkf_UPE2OFgT_WhtzK8IDlcEkQn4HmYwJ5pe3t6ssgdL7Pf-oSPfz3-cWQa_AEwAlD4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>TGF-[beta]2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing</title><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Koch, Drew W ; Schnabel, Lauren V ; Ellis, Ilene M ; Bates, Rowan E ; Berglund, Alix K</creator><creatorcontrib>Koch, Drew W ; Schnabel, Lauren V ; Ellis, Ilene M ; Bates, Rowan E ; Berglund, Alix K</creatorcontrib><description>Background Mesenchymal stem cells (MSCs) secrete paracrine factors and extracellular matrix proteins that contribute to their ability to support tissue healing and regeneration. Both the transcriptome and the secretome of MSCs can be altered by treating the cells with cytokines, but neither have been thoroughly investigated following treatment with the specific cytokine transforming growth factor (TGF)-[beta]2. Methods RNA-sequencing and western blotting were used to compare gene and protein expression between untreated and TGF-[beta]2-treated equine bone marrow-derived MSCs (BM-MSCs). A co-culture system was utilized to compare equine tenocyte migration during co-culture with untreated and TGF-[beta]2-treated BM-MSCs. Results TGF-[beta]2 treatment significantly upregulated gene expression of collagens, extracellular matrix molecules, and growth factors. Protein expression of collagen type I and tenascin-C was also confirmed to be upregulated in TGF-[beta]2-treated BM-MSCs compared to untreated BM-MSCs. Both untreated and TGF-[beta]2-treated BM-MSCs increased tenocyte migration in vitro. Conclusions Treating equine BM-MSCs with TGF-[beta]2 significantly increases production of paracrine factors and extracellular matrix molecules important for tendon healing and promotes the migration of tenocytes in vitro. Keywords: Mesenchymal stem cell, Tenocyte, TGF-[beta], Equine, Tendon, RNA-sequencing, Paracrine factors, Extracellular matrix</description><identifier>ISSN: 1757-6512</identifier><identifier>EISSN: 1757-6512</identifier><identifier>DOI: 10.1186/s13287-022-03172-9</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Collagen ; Cytokines ; Gene expression ; Genes ; Stem cells ; Transforming growth factors</subject><ispartof>Stem cell research &amp; therapy, 2022-09, Vol.13 (1)</ispartof><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Koch, Drew W</creatorcontrib><creatorcontrib>Schnabel, Lauren V</creatorcontrib><creatorcontrib>Ellis, Ilene M</creatorcontrib><creatorcontrib>Bates, Rowan E</creatorcontrib><creatorcontrib>Berglund, Alix K</creatorcontrib><title>TGF-[beta]2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing</title><title>Stem cell research &amp; therapy</title><description>Background Mesenchymal stem cells (MSCs) secrete paracrine factors and extracellular matrix proteins that contribute to their ability to support tissue healing and regeneration. Both the transcriptome and the secretome of MSCs can be altered by treating the cells with cytokines, but neither have been thoroughly investigated following treatment with the specific cytokine transforming growth factor (TGF)-[beta]2. Methods RNA-sequencing and western blotting were used to compare gene and protein expression between untreated and TGF-[beta]2-treated equine bone marrow-derived MSCs (BM-MSCs). A co-culture system was utilized to compare equine tenocyte migration during co-culture with untreated and TGF-[beta]2-treated BM-MSCs. Results TGF-[beta]2 treatment significantly upregulated gene expression of collagens, extracellular matrix molecules, and growth factors. Protein expression of collagen type I and tenascin-C was also confirmed to be upregulated in TGF-[beta]2-treated BM-MSCs compared to untreated BM-MSCs. Both untreated and TGF-[beta]2-treated BM-MSCs increased tenocyte migration in vitro. Conclusions Treating equine BM-MSCs with TGF-[beta]2 significantly increases production of paracrine factors and extracellular matrix molecules important for tendon healing and promotes the migration of tenocytes in vitro. Keywords: Mesenchymal stem cell, Tenocyte, TGF-[beta], Equine, Tendon, RNA-sequencing, Paracrine factors, Extracellular matrix</description><subject>Collagen</subject><subject>Cytokines</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Stem cells</subject><subject>Transforming growth factors</subject><issn>1757-6512</issn><issn>1757-6512</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNptkMlKBDEQhhtRUNQX8BQQBA_RJL3mKKKjIAguJ5GhOl09He1OtCvj6FP4ysblMAMmkArF99fyJ8meFEdSVsUxyVRVJRdKcZHKUnG9lmzJMi95kUu1vvTfTHaJnkQ8aSpEkW0ln3eTc_5QY4BHxdB14AwSw_eXEYmsd8y3DF_n1iGrfXwGGEe_4A2O9g0bNiChM93HAD2jgAMz2PfsBUYw47emBRP8SGxhQ8eenV84BkTeWAixOLHgWUDXxD4dQm_dbCfZaKEn3P2L28n9-dnd6QW_up5cnp5c8VlcNuNaZ2XaaMxB6VKkaFArpaGtZUzKItqQ11VdQa5SFFDLulUV5hrrymSNLpp0O9n_rTuDHqfWtT7EmQdLZnpSykqoTOosUkf_UPE2OFgT_WhtzK8IDlcEkQn4HmYwJ5pe3t6ssgdL7Pf-oSPfz3-cWQa_AEwAlD4</recordid><startdate>20220916</startdate><enddate>20220916</enddate><creator>Koch, Drew W</creator><creator>Schnabel, Lauren V</creator><creator>Ellis, Ilene M</creator><creator>Bates, Rowan E</creator><creator>Berglund, Alix K</creator><general>BioMed Central Ltd</general><scope>ISR</scope></search><sort><creationdate>20220916</creationdate><title>TGF-[beta]2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing</title><author>Koch, Drew W ; Schnabel, Lauren V ; Ellis, Ilene M ; Bates, Rowan E ; Berglund, Alix K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1324-99473d9e5a29703ece9229afb1d9e160315b8b8a523e0ab1bf28e59eb8c4d96d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Collagen</topic><topic>Cytokines</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Stem cells</topic><topic>Transforming growth factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koch, Drew W</creatorcontrib><creatorcontrib>Schnabel, Lauren V</creatorcontrib><creatorcontrib>Ellis, Ilene M</creatorcontrib><creatorcontrib>Bates, Rowan E</creatorcontrib><creatorcontrib>Berglund, Alix K</creatorcontrib><collection>Gale In Context: Science</collection><jtitle>Stem cell research &amp; therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koch, Drew W</au><au>Schnabel, Lauren V</au><au>Ellis, Ilene M</au><au>Bates, Rowan E</au><au>Berglund, Alix K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TGF-[beta]2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing</atitle><jtitle>Stem cell research &amp; therapy</jtitle><date>2022-09-16</date><risdate>2022</risdate><volume>13</volume><issue>1</issue><issn>1757-6512</issn><eissn>1757-6512</eissn><abstract>Background Mesenchymal stem cells (MSCs) secrete paracrine factors and extracellular matrix proteins that contribute to their ability to support tissue healing and regeneration. Both the transcriptome and the secretome of MSCs can be altered by treating the cells with cytokines, but neither have been thoroughly investigated following treatment with the specific cytokine transforming growth factor (TGF)-[beta]2. Methods RNA-sequencing and western blotting were used to compare gene and protein expression between untreated and TGF-[beta]2-treated equine bone marrow-derived MSCs (BM-MSCs). A co-culture system was utilized to compare equine tenocyte migration during co-culture with untreated and TGF-[beta]2-treated BM-MSCs. Results TGF-[beta]2 treatment significantly upregulated gene expression of collagens, extracellular matrix molecules, and growth factors. Protein expression of collagen type I and tenascin-C was also confirmed to be upregulated in TGF-[beta]2-treated BM-MSCs compared to untreated BM-MSCs. Both untreated and TGF-[beta]2-treated BM-MSCs increased tenocyte migration in vitro. Conclusions Treating equine BM-MSCs with TGF-[beta]2 significantly increases production of paracrine factors and extracellular matrix molecules important for tendon healing and promotes the migration of tenocytes in vitro. Keywords: Mesenchymal stem cell, Tenocyte, TGF-[beta], Equine, Tendon, RNA-sequencing, Paracrine factors, Extracellular matrix</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s13287-022-03172-9</doi></addata></record>
fulltext fulltext
identifier ISSN: 1757-6512
ispartof Stem cell research & therapy, 2022-09, Vol.13 (1)
issn 1757-6512
1757-6512
language eng
recordid cdi_gale_infotracmisc_A718024194
source Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Collagen
Cytokines
Gene expression
Genes
Stem cells
Transforming growth factors
title TGF-[beta]2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T23%3A36%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TGF-%5Bbeta%5D2%20enhances%20expression%20of%20equine%20bone%20marrow-derived%20mesenchymal%20stem%20cell%20paracrine%20factors%20with%20known%20associations%20to%20tendon%20healing&rft.jtitle=Stem%20cell%20research%20&%20therapy&rft.au=Koch,%20Drew%20W&rft.date=2022-09-16&rft.volume=13&rft.issue=1&rft.issn=1757-6512&rft.eissn=1757-6512&rft_id=info:doi/10.1186/s13287-022-03172-9&rft_dat=%3Cgale%3EA718024194%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A718024194&rfr_iscdi=true